Article
The development and characterization of an scFv-Fc fusion based gene therapy to reduce the…
medRxiv · 2019 · Charles E. Hay
Key facts
| Title | The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse |
|---|---|
| First author | Charles E. Hay |
| Journal | medRxiv |
| Published | Jun 29, 2019 |
| DOI | 10.1101/687129 |
| Devices mentioned | 213498 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1